just in time for the semester to end and to take it all down. Sadly, that emergency party never did arrive.

Sublimation is, by definition, solid-->gas without forming a liquid intermediate.

Summary and TFA seem to skim over the main area where this technology will likely see application--in looking at drug permeability and transport across the intestinal membrane. This is something that gets examined for EVERY orally administered drug and right now this is done primarily with cell culture monolayers of intestinal cells. This model allows for the addition of peristaltic forces and other stressors to give a more physiologically relevant system.

Lightening even.

I don't know, with that tin foil hat maybe you should be more worried about lighting too.

Any takers on how many trojans/rootkits this guy is hoarding?

To scan 200,000 lottery tickets and sort out the winners.

There != their

You clearly misunderstood the post you're responding to, or are yourself, an

The poster implied that he would sell the rights to a pharma company and indeed licensing compounds from smaller companies/research labs is indeed standard practice. If you meant that the pharma companies don't have enough new drugs of their own, this is in fact wrong.

The second part of the post implied the kid would never be heard from again. If he made enough money it's possible. I'm guessing you misinterpreted this as a statement the company would buy his compound and it would never see the light of day, thus garnering your idiot comment. While it's not what he meant, it is in fact also common practice in pharma for companies to license the rights to compounds similar to those they are developing just to eliminate potential competition. It's why often when licensing a compound stipulations are added that the purchasing company must intend to develop it.

All of this is likely moot as the kid does not own the rights to the compounds. TFA doesn't specify whether they are novel but my guess would be he worked with a library of existing compounds that showed some activity against cystic fibrosis in preliminary screenings.

Okay, we'll be Planet A and you can be Planet 1.